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Key messages
What is already known about this subject?
 Ź Patients with heart failure should be referred to car-
diac rehabilitation; however, less than 20% of eligi-
ble patients access such services.
 Ź Exercise training and physical activity have been 
shown to beneit patients, yet too few programmes 
assess itness prior to starting rehabilitation.
 Ź Little is known about which clinical and patient 
characteristics determine itness.
What does this study add?
 Ź This study is the irst to determine the extent by 
which comorbidities determine walking itness in 
patients with a primary diagnosis of heart failure.
How might this impact on clinical practice?
 Ź These indings have led to the development of walk-
ing itness reference values which can be used by 
clinicians and patients to understand their level of 
itness and help set realistic goals as part of their 
cardiac rehabilitation programme and long-term 
self-management.
ABSTRACT
Introduction Patients with heart failure (HF) attending 
cardiac rehabilitation (CR) beneit in terms of improved 
quality of life, physical itness and reduced hospital 
admissions. Too few patients with HF attend CR and little 
data exist on the characteristics of those who do especially 
in respect of physical itness. This study evaluates 
the extent by which clinical and demographic factors 
determine walking itness in patients with a primary 
diagnosis of HF.
Methods Clinical data from the British Heart Foundation 
National Audit of Cardiac Rehabilitation identiied 1519 
patients with HF who completed an incremental shuttle 
walk test (ISWT). Stepwise regression accounting for age, 
gender and multiple potential confounders assessed their 
contribution to total walking distance.
Results Mean age was 64.5 (SD 12.70) years with a 
range of ISWT distances across gender and associated 
comorbidities from 215 to 282 m. Walking distance 
reduced by 4.9 m for each year increase in age above 
mean age (p<0.001). After accounting for confounders, 
females walked 42.1 m less than males (p≤ 0.001). 
Pulmonary disease and the existence of depression 
was associated with a 39.3 and 52.2 m reduction in 
walking distance, respectively. Body mass index >30 was 
associated with 28.5 m reduction in walking distance 
(p<0.001). HF severity failed to improve the regression 
model it or achieve signiicance in the analysis
Conclusions Age, gender and the presence of pulmonary 
disease or depression were highly signiicant factors in 
predicting walking itness in patients with HF. The study 
also produced a set of reference values based on these 
four factors to aid the interpretation of walking itness in 
patients with HF.
INTRODUCTION
Cardiac rehabilitation (CR) for patients with 
coronary heart disease and those with heart 
failure (HF) is a clinically effective interven-
tion that has yet to achieve optimal uptake in 
routine clinical practice.1–3 The stated ambi-
tion of NHS England is to improve uptake 
from 45% in 2014 to greater than 65% by 
2020 which is an initiative that aligns with the 
National Institute for Health and Care Excel-
lence guidance recommendations in the UK4 5 
and international guidance.6 7 Cardiologists 
and cardiac nurses play a fundamental role 
in the early treatment and management of 
heart disease and they represent the primary 
source of referral to CR.8
National audit data from the UK3 show 
that uptake to CR is around 50% for patients 
with acute coronary syndrome and equiva-
lent to one-third in European and American 
CR programmes.9 10 The situation is much 
worse for patients with HF where uptake is 
less than 20% of all eligible patients in the 
UK.3 11 Referral to CR for patients with HF 
has yet to become routine practice with most 
programmes already stretched by the sheer 
volume of patients attending through the 
conventional cardiology referral pathways.3 12
We hypothesise that one of the reasons so 
few patients with HF attend CR and many 
programmes are unable to recruit patients 
with HF is, in part, due to a perception that 
‘exercise training and rehabilitation’ are at 
odds with a patient’s diagnosis of HF. There 
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is an urgent need to create a more realistic view of what 
a patient with HF can achieve in terms of physical exer-
cise and fitness. Although clinical trial data on HF exist 
suggesting what is possible in terms of maximal exercise 
capacity, obtained from cardiopulmonary exercise testing 
(CPET), this tends to be based on an exclusive popula-
tion that are much younger, by as much as 11 years, and 
have fewer comorbidities1 compared with patients who 
attend routine practice CR.3
The incremental shuttle walk test (ISWT) is the most 
commonly used test of functional physical fitness in the 
UK.3 Although the ISWT does not represent a ‘criterion 
maximal test’, of exercise capacity it is a recommended 
submaximal surrogate measure of exercise capacity13 that 
is positively validated against CPET.14 Some studies have 
used the ISWT to investigate potential determinants of 
walking fitness in conventional cardiac patients15 16 iden-
tifying age, height, body mass index (BMI) and the pres-
ence of diabetes as significant predictors of distanced 
achieved. The New York Heart Association (NYHA) Func-
tional Classification is an established symptom and func-
tion-aligned measure, classifying the extent of HF severity 
in patients, yet has not been investigated for its role in 
determining walking fitness as measured by the ISWT in 
HF.
This study aims to investigate and assess the strength of 
association between walking fitness and relevant patient 
demographics, risk factors, comorbidities and severity of 
HF. Our findings aim to create new knowledge to guide 
clinical decisions about the characteristics of patients 
with HF taking part in exercise-based CR.
METHODS
This study used a robust observational methodology 
to evaluate the potential contribution of individual 
patient characteristics in defining physical fitness in 
patients with HF attending a CR assessment.
Data
The study used data from a routinely collected audit of 
CR, British Heart Foundation (BHF) and the National 
Audit of Cardiac Rehabilitation (NACR). The NACR 
collects data from CR programmes across the UK and 
has a 74% coverage for electronic data entry.3 The elec-
tronic data were acquired in a link-anonymised format 
from 224 programmes, which collect data on patient’s 
demographics, risk factors and baseline measures prior 
to starting CR. The data collection of patient informa-
tion is covered by Section 251 approval which is reviewed 
by NHS Digital annually, the rationale for data collec-
tion was to improve the quality of CR service delivery 
for public benefit. Patients were included if they had 
an initiating event (primary diagnosis of HF) between 
1 January 2013 and 30 October 2018. To account for 
potential reporting bias through missing data, the HF 
population without an ISWT score was compared with 
the ISWT group in the context of age and gender. A 
planned subanalysis investigated the extent by which 
HF severity, defined by the NYHA Functional Classifica-
tion, determined walking fitness.
The primary variable of interest (dependant vari-
able) is maximum distance walked in metres measured 
by the ISWT as part of a prerehabilitation assessment. 
The ISWT is an externally paced (via audio player) and 
graded walk test with 12 levels of speed that has been 
validated in cardiac and pulmonary rehabilitation popu-
lations.14 17 Although the test result can be reported 
by the speed level achieved our planned analysis used 
distance walked as a continuous variable in the linear 
regression model which also enabled us to pursue refer-
ence values using a measure (metres walked) which are 
more relevant to clinicians and patients.
Statistical analysis
The analyses were conducted in IBM statistical package 
SPSS V.25 (SPSS). Correlation and group compari-
sons used t-tests and Pearson correlation, respectively. 
Subject to having sufficient data to fulfil statistical distri-
bution assessments (n>30) all potential covariates were 
investigated in the analysis. Backwards stepwise linear 
regression models were built to investigate whether, 
accounting for covariates, the patient-level factors were 
associated with walking fitness as measured by ISWT 
distance.
Relevant important covariates were included in the 
analysis, where they were evidenced in the literature or 
significant in preliminary analysis. Age (years), gender 
(male/female), marital status (single/not) and employ-
ment status have been shown to influence the outcomes 
following a variety of different rehabilitation interven-
tions, including CR. Employment status was coded 
as employed/retired or unemployed, this is because 
previous research found that employed and retired 
states have similar effects on outcomes. Other risk 
factors such as BMI, physical activity, smoking status, 
psychosocial well-being measured through Hospital 
Anxiety Depression Scale (HADS) score and comor-
bidity were included as they are routinely reported by 
the NACR as variables that influence patient engage-
ment with CR.3 8
Statistical level for significance was p<0.05 and actual 
significant values were expressed as reported up to 
0.001. Data model checking was performed to ensure 
that the models were a good fit through assumptions 
associated with the regressions.
RESULTS
This study consisted of 1519 patients (68% male) with 
HF who had completed an ISWT. The mean age for 
total population was 64.5 (SD 12.7) years. Table 1 shows 
the average ISWT distances in metres for each of the 
included variables. The overall mean distance was 266.6 
m (156.4 SD). Pearson correlation indicates that there 
is a significant negative relationship between age and 
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Table 1 Incremental shuttle walk test (ISWT) distance for all included variables
Patient characteristics 
ISWT distance (m)
Mean SD Count %
Pearson correlation 
(PC)/mean difference 
(MD)/F stat ANOVA (F) P value
Age 64.51 12.70 1519 −0.40 (PC) <0.001
Gender 
  Male 284.3 162.65 1035 68 55.71 (MD) <0.001
  Female 228.6 134.94 482 32
Ethnicity 
  White 263.7 151.47 1136 75 −11.74 (MD) 0.204
  Non-white 275.4 170.15 383 25
Smoking Status 
  No 266.5 153.31 1304 93 −10.61 (MD) 0.503
  Yes 277.1 179.31 104 7
Physical activity status 
  No 246.5 153.92 887 68 −60.85 (MD) <0.001
  Yes 307.4 149.56 408 32
Body mass index (BMI) 
  <30 276.2 163.18 827 59 25.42 (MD) 0.002
  >30 250.8 138.64 586 41
Employment status 
  Employed 262.5 152.63 995 79 −9.53 (MD) 0.366
  Unemployed 272.1 156.78 266 21
Marital status 
  Single 246.9 157.08 359 31 −19.36 (MD) 0.039
  Partner 266.2 143.44 799 69
HADS score: Anxiety 
  Not anxious 271.6 155.81 1042 83 36.79 (MD) 0.002
  Anxious 234.8 145.82 209 17
HADS score: Depression 
  Not depressed 274.2 154.71 1082 86 64.78 (MD) <0.001
  Depressed 209.4 143.38 169 14
IMD score 
  Lowest quintile 265.5 173.68 263 22.1 0.43 (F) 0.789
  Second quintile 256.6 163.18 277 23.3
  Third quintile 259.6 144.28 221 18.6
  Fourth quintile 267.9 157.85 232 19.5
  Fifth quintile 274.3 161.18 196 16.5
Total population ISWT score 266.6 156.41
ANOVA, analysis of variance; HADS, Hospital Anxiety Depression Scale; IMD, Index of Multiple Deprivation; MD, mean difference; PC, 
pearson correlation.
ISWT distance of −0.40 (p≤0.001), which was stronger 
for females (r=−0.436) than males (r=−0.391).
In absolute terms males had a significantly larger 
ISWT distance on average 55.7 m greater than 
females (p≤0.001). Patients with a history of achieving 
moderate physically active status had on average a statis-
tically significant 60.9 m greater distance than those 
who were not (p≤0.001). Patients with BMI greater 
than 30 demonstrated shorter ISWT distances by on 
average 25.4 m (p=0.002). Marital status of patients was 
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significantly associated with walking fitness, those with a 
partner had 19.4 m greater than those single (p=0.039). 
No other variables were associated with differences in 
ISWT distance. Patients who were either anxious or 
depressed at baseline, HADS score ≥8, had significantly 
lower walking distances than those patients with HADS 
score below 8 (p<0.05).
Additionally, the study included as subset analysis the 
inclusion of NYHA class I–IV, the analysis failed to find 
any significant differences between the NYHA class and 
ISWT distance (p>0.05).
Table 2 shows the ISWT distance, when analysed 
against the patient’s comorbidity status. Eighteen 
comorbidities captured on the NACR were included, 
along with a single-variable coding multimorbidity of ≤3 
or 3+. The results showed that patients having angina, 
arthritis, diabetes, stroke, hypertension, chronic 
obstructive pulmonary disease (COPD), asthma and 
chronic back problems demonstrated significantly 
lower ISWT distance (mean difference range 28.2–55.3, 
p<0.05).
The number of comorbidities was also significant 
with a 42.19 m reduced mean difference with having 
more than three comorbidities.
Table 3 shows the results from the linear regression 
evaluating the association between ISWT distance 
against patient characteristics and related risk factors. 
The model confirms that age, after accounting for 
multiple potential confounders, was negatively asso-
ciated ISWT distance (B=−4.868, p<0.001). The effect 
of age is centralised around the mean suggesting that 
for each single-year increase in age, above the mean, 
there is an associated 5.5 m reduction in distance 
walked.
Gender plays a significant part in determining walking 
fitness with female patients having a 42 m reduced 
walking distance (p<0.001). Other covariates of statis-
tical significance associated were ethnicity, employment 
status, marital status, physical activity, BMI and socioeco-
nomic class. Patients being unemployed, with greater 
BMI and not achieving physical activity status were all 
associated with a lower ISWT score between 29 and 50 
m (p=0.05–0.001). For every increase in socioeconomic 
class quintile the patient’s baseline ISWT increased by 
8.5 m, thus being from the lowest as opposed to the 
highest quintiles was a difference of 44 m (p=0.002). 
Patients being identified as clinically or borderline 
depressed at baseline using the HADS score performed 
on average 52 m worse than those who were classified 
as normal (p<0.001).
Variables that were not significant such as smoking 
status, other covariates and multimorbidity were auto-
matically removed from the backward stepwise analysis.
The model was of good fit and the residuals met the 
assumptions of uniform variance and linearity, and the 
adjusted r2 value was 0.266. The grouping of comorbidi-
ties into less than or greater than 3 was not significantly 
associated with walking fitness. Subset analysis showed 
that the model with NYHA was not of greater fit. The 
inclusion of NYHA class was not statistically significant.
Table 4 presents our proposed reference values for 
ISWT distance split by age, gender and COPD set within 
5, 25, 75 and 95 percentiles.
DISCUSSION
Reassuringly our findings showed that patients with a 
primary diagnosis of HF, referred to CR, were capable of 
levels of walking fitness, achieved through challenging 
incremental test, comparable to the 25th–50th centiles 
of patients with conventional cardiovascular disease 
attending CR.17 Although the extent of walking fitness 
was greater by 42 m in the group with fewer comorbid-
ities (≤3), a good mean distance of 240 m was achieved 
in the group having greater than three additional 
comorbidities. These findings help establish a positive 
picture in terms of physical fitness for those patients 
with the diagnosis of HF and willingness to engage in 
rehabilitation.
Using mean age of the study population (64.5±12.7) 
as a reference value, being older by 1 year was signifi-
cantly associated with reduced walking distances in the 
region of 4.9 m for each year above mean age. This rela-
tionship is not new as it is evident in the conventional 
CR patient populations16 17; however, the ability to quan-
tify the extent of loss, with increasing age, represents a 
novel finding in patients with HF.
After accounting for comorbidities gender continues 
to play a significant part in determining walking fitness 
with female patients having a 42 m reduced walking 
distance. The CR literature and routine practice data, 
captured in national reports,3 highlight that around 
80% of patients with HF are missing out on CR and of 
those who do attend around one-third have a recorded 
physical fitness assessment.3 11 National clinical guid-
ance worldwide recommends assessment of physical 
fitness prior to starting CR6 7 13 yet two-thirds of patients 
in the UK are not assessed. In terms of HF the lack 
of physical assessment may not purely be the fault of 
programmes and could, in part, be explained by the 
incapacity of patients or in some cases a perceived inca-
pacity to carry out a walk test especially an incremental 
test. Our research has produced reference values to 
help clarify physical fitness expectations for patients 
with HF attending CR and for clinicians to aid goal 
setting at the start of CR (table 4).
A knowledge of age and gender differences in walking 
fitness aligned with fitness determining comorbidities 
such as COPD and depression, as shown in table 4, is 
considered useful in clarifying HF-specific physical 
fitness expectations for CR programme staff, patients 
and carers.
The presence of COPD in the form of chronic bron-
chitis or emphysema is significant in predicting fitness 
in patients with HF resulting in a 39 m reduction 
walking distance. COPD is dominated by the symptom 
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Table 2 Incremental shuttle walk test (ISWT) distance reported by comorbidity category
ISWT distance (m)
Mean SD Count % Mean difference P value
Angina 
  No 270.0 158.5 1419 93 51.6 0.001
  Yes 218.5 114.1 110 7
Arthritis 
  No 276.3 158.3 1262 83 57.1 <0.001
  Yes 219.2 137.5 257 17
Cancer 
  No 268.6 158.7 1383 91 22.0 0.117
  Yes 246.6 130.2 136 9
Diabetes 
  No 276.7 161.1 1207 79 48.8 <0.001
  Yes 227.9 129.9 312 21
Stroke 
  No 270.0 158.0 1424 94 53.1 0.001
  Yes 216.9 120.6 95 6%
Hypertension 
  No 276.6 164.1 982 65 28.2 0.001
  Yes 248.4 139.6 537 35
Chronic obstructive pulmonary disease 
  No 270.6 157.8 1409 93 55.3 0.001
  Yes 215.4 126.9 110 7
Asthma 
  No 269.2 157.8 1394 92 31.4 0.031
  Yes 237.8 137.1 125 8
Chronic back problems 
  No 272.0 158.5 1306 86 38.1 0.001
  Yes 233.8 138.7 213 14
Anxiety 
  No 265.8 156.0 1402 92 −11.4 0.449
  Yes 277.2 161.9 117 8
Depression 
  No 268.3 158.8 1372 90 16.8 0.217
  Yes 251.5 131.4 147 10
Family history 
  No 266.0 159.1 1253 82 −3.5 0.741
  Yes 269.5 143.1 266 18
Erectile dysfunction 
  No 267.3 157.4 1436 95 12.9 0.466
  Yes 254.5 138.5 83 5
Hypercholesterolaemia/dislipidaemia 
  No 269.0 159.0 1280 84 15.3 0.166
  Yes 253.8 141.7 239 16
Comorbidities grouped 
  ≤3 282.0 166.0 967 64 42.2 <0.001
  >3 239.8 134.1 552 36
Osteoporosis, claudication and rheumatism were removed due to insuficient subset sample sizes (n≤25).
 o
n
 4 M
arch 2019 by guest. Protected by copyright.
http://openheart.bmj.com/
O
pen Heart: first published as 10.1136/openhrt-2018-000866 on 27 February 2019. Downloaded from
 
Open Heart
6 Doherty P, et al. Open Heart 2019;6:e000866. doi:10.1136/openhrt-2018-000866
Table 3 Linear regression indings for the incremental shuttle walk test (ISWT) by patient characteristics
Patient characteristics B SE t Significance 95% CI
Gender (Female) −42.123 10.658 −3.952 <0.001 −63.055 to −21.191
Age −4.868 0.447 −10.888 <0.001 −5.746 to −3.990
Ethnicity (Non-white) −23.347 13.340 −1.750 0.081 −49.545 to 2.852
Physical activity status (150 min/week) 43.467 10.543 4.123 <0.001 22.761 to 64.173
BMI (>30) −28.645 10.203 −2.808 0.005 −48.682 to −8.607
Employment status (Unemployed) −50.336 12.951 −3.887 <0.001 −75.771 to −24.901
Diabetes −33.448 12.318 −2.715 0.007 −57.639 to −9.257
Chronic back problems (Yes) −36.855 13.392 −2.752 0.006 −63.155 to −10.554
COPD (Yes) −39.310 18.937 −2.076 0.038 −76.501 to −2.119
HADS score: Depression (Depressed) −52.194 14.842 −3.517 <0.001 −81.342 to −23.045
IMD score 11.624 3.801 3.058 0.002 4.160 to 19.088
Intercept 276.703 13.339 20.744 <0.001 250.506 to 302.899
R=0.530. R2=0.281. Adj R2=0.266.
BMI, body mass index; COPD, chronic obstructive pulmonary disease; HADS, Hospital Anxiety Depression Scale; IMD, Index of Multiple 
Deprivation.
Table 4 Incremental shuttle walk test reference values for patients with heart failure (HF) split by age, gender and presence of 
chronic obstructive pulmonary disease (COPD) and depression
Heart failure 
(HF)+comorbidity 
category
Age and 
gender 
Incremental shuttle walk test (ISWT)
Count
Mean 
distance
(m) SD
Percentile 
05
Percentile 
25
Percentile 
75
Percentile 
95
HF only <67 years 
Male 338 180 70 200 460 630 443
Female 285 145 70 190 350 520 190
67+ years 
Male 243 138 60 140 330 480 434
Female 184 109 40 100 250 390 211
HF+COPD <67 years 268 237 133 40 120 330 430
67+ years 194 197 120 40 90 270 470
HF+Depression <67 years 237 261 143 30 150 340 520
67+ years 181 233 107 70 155 295 420
of breathlessness, at rest, and exacerbated by physical 
effort which on top of the diagnosis of HF possibly 
explains such lower levels of fitness.18 The severity of 
HF as measured by NYHA did not reach significance 
as a determinant which might be explained by the 
analysis accounting for COPD. Within the NYHA class 
groups the proportion with COPD was 4% for class 1, 
5% for class 2, 11% for class 3% and 31% for class 4. 
The inter-relation between HF and COPD is becoming 
increasingly important clinically leading to a call for a 
service provision aimed at managing breathlessness in 
patients with these comorbidities.18
A new finding for patients with HF was that higher 
levels of depression, measured using HADS, were 
strongly associated with poorer walking fitness. This 
has not been investigated previously in HF; however, 
our findings concur with a robust systematic review in 
healthy and depressed adult populations where depres-
sion and physical fitness were found to be inversely 
correlated.19
Table 4 incorporates the impact of COPD and depres-
sion on walking fitness reference values for younger and 
older patients with the combination of HF+COPD or 
HF+depression. This is the first set of reference values 
to account for the presence of such variables alongside 
HF which should enable clinicians to better under-
stand physical fitness differences and/or expectations 
of their patients.
Our findings have generated new knowledge to help 
guide clinical decisions about the suitability of patients 
with HF to take part in exercise-based CR. The study 
also produced a set of reference values aligned with 
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age, gender, COPD and depression to aid the interpre-
tation of walking fitness in patients with HF in the hope 
that this new knowledge will help improve referral and 
uptake to CR.
Limitations
Although the study investigated a large number of 
covariates, we were unable to account for medica-
tions such as diuretics and beta-blockers that may have 
accounted for some variation within the population in 
terms of weight gain and walking fitness, respectively.
Concerning our subanalysis of HF severity using 
NYHA there was a potential reporting bias through 
missing data. Although we cannot rule this out our 
analysis of the population with and without a recorded 
NYHA classification showed no significant differences 
for age and gender.
The mean age of patients recruited was 64.5 (SD 
12.7) years which is below that seen in the general HF 
population. Our approach to ISWT reference values 
utilises the median distribution above and below 67 
years which better reflects the full range of patients.
CONCLUSION
The study concludes that patient age, gender, ethnicity, 
physical activity and depression status, along with the 
presence of COPD as comorbidity, were significant 
factors in predicting walking fitness in patients with 
HF. This is the first study to clarify the extent by which 
patient characteristics determine walking fitness in 
patients with HF and these findings have the potential 
to aid clinician understanding of the levels of fitness 
patients with HF can achieve. The study produced a 
novel set of reference values, aligned with age, gender, 
COPD and depression, to aid the interpretation of 
walking fitness by clinicians and patients. Through 
dissemination of these findings we believe this knowl-
edge has potential to improve confidence in clinicians 
making a referral to CR and lead to a greater number of 
patients undergoing a physical fitness assessment thus 
enabling an appropriate exercise prescription.
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